X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3417) 3417
Book Chapter (44) 44
Dissertation (8) 8
Publication (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
thromboprophylaxis (3085) 3085
humans (2129) 2129
venous thromboembolism (1580) 1580
prevention (1256) 1256
female (1207) 1207
thromboembolism (1119) 1119
male (980) 980
risk factors (866) 866
deep-vein thrombosis (852) 852
enoxaparin (840) 840
prophylaxis (808) 808
hematology (787) 787
anticoagulants - therapeutic use (785) 785
thrombosis (781) 781
middle aged (780) 780
molecular-weight heparin (764) 764
surgery (764) 764
venous thromboembolism - prevention & control (743) 743
aged (711) 711
peripheral vascular disease (666) 666
adult (654) 654
anticoagulants (603) 603
pulmonary-embolism (507) 507
pulmonary embolism (496) 496
risk (481) 481
rivaroxaban (478) 478
anticoagulants - administration & dosage (420) 420
venous thromboembolism - etiology (401) 401
venous thrombosis - prevention & control (396) 396
heparin (384) 384
orthopedics (371) 371
medicine, general & internal (361) 361
treatment outcome (358) 358
retrospective studies (356) 356
anticoagulants - adverse effects (345) 345
pregnancy (344) 344
deep vein thrombosis (334) 334
risk assessment (332) 332
double-blind (330) 330
postoperative complications - prevention & control (328) 328
aged, 80 and over (318) 318
risk-factors (315) 315
venous thrombosis (309) 309
heparin, low-molecular-weight - therapeutic use (299) 299
cancer (294) 294
warfarin (292) 292
abridged index medicus (286) 286
incidence (274) 274
arthroplasty (269) 269
anticoagulation (257) 257
analysis (254) 254
medicine & public health (251) 251
mortality (243) 243
venous thromboembolism - epidemiology (243) 243
venous thrombosis - etiology (236) 236
prospective studies (232) 232
complications (227) 227
thromboembolism - prevention & control (227) 227
unfractionated heparin (227) 227
drug therapy (220) 220
metaanalysis (219) 219
pulmonary embolism - prevention & control (211) 211
apixaban (210) 210
health aspects (207) 207
hemorrhage - chemically induced (206) 206
pharmacology & pharmacy (203) 203
aspirin (192) 192
cardiac & cardiovascular systems (192) 192
care and treatment (192) 192
health risk assessment (189) 189
administration, oral (188) 188
research (186) 186
deep venous thrombosis (185) 185
replacement (184) 184
safety (183) 183
dabigatran etexilate (180) 180
fibrinolytic agents - therapeutic use (177) 177
adolescent (176) 176
patients (176) 176
total knee arthroplasty (174) 174
low-molecular-weight heparin (173) 173
practice guidelines as topic (173) 173
guidelines (172) 172
dabigatran (171) 171
oncology (169) 169
time factors (161) 161
arthroplasty, replacement, knee - adverse effects (160) 160
management (160) 160
young adult (159) 159
total hip-replacement (157) 157
factor xa inhibitors (156) 156
pulmonary embolism - etiology (156) 156
bleeding (154) 154
low molecular weight heparin (152) 152
therapy (151) 151
thrombosis - prevention & control (150) 150
obstetrics & gynecology (149) 149
prolonged thromboprophylaxis (149) 149
hospitalization (147) 147
heparin, low-molecular-weight - administration & dosage (144) 144
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3217) 3217
German (109) 109
French (76) 76
Spanish (70) 70
Japanese (14) 14
Portuguese (14) 14
Russian (14) 14
Polish (11) 11
Czech (7) 7
Italian (5) 5
Hungarian (4) 4
Korean (4) 4
Norwegian (3) 3
Slovak (3) 3
Slovenian (2) 2
Bosnian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Farge, Dominique and Frere, Corinne and Connors, Jean M and Ay, Cihan and Khorana, Alok A and Munoz, Andres and Brenner, Benjamin and Kakkar, Ajay and Rafii, Hanadi and Solymoss, Susan and Brilhante, Dialina and Monreal, Manuel and Bounameaux, Henri and Pabinger, Ingrid and Douketis, James and Ageno, Walter and Ajauro, Fernando and Al-Aboudi, Kamal R and Alcindor, Thierry and Andre, Thierry and Angchaisuksiri, Pantep and Antic, Darko and Arcelus, Juan I and Assenat, Eric and Bauer, Kenneth A and Bazarbachii, Ali and Benzidia, Ilham and Beyer-Westendorf, Jan and Bitsadze, Viktoria and Blickstein, Dorit and Blostein, Mark and Bogalho, Isabel and Bournet, Barbara and Casais, Patricia and Carpentier, Antoine F and Cesarman-Maus, Gabriela and Chakbrabartty, Joydeep and Clemente, Hugo and Connault, Jérôme and Doucet, Ludovic and Durant, Cécile and Emmerich, Joseph and Falanga, Anna and Feistritzer, Clemens and Font, Carme and Francis, Charles and Gallardo, Enrique and Gary, Thomas and Gris, Jean-Christophe and Guillermo, Cecilia and Hij, Adrian and Hull, Russel D and IKezoe, Takayuki and Jara-Palomares, Luis and Key, Nigel S and Khrizroeva, Jamilya and Koolian, Maral and Langer, Florian and Le Hello, Claire and Lecumberri, Ramón and Lee, Lai Heng and Liebman, Howard and Lopes Dos Santos, Luisa and Machado, Duarte Henrique and Madelaine, Isabelle and Makatsariya, Alexander and Mandala, Mario and Marayevas, Anthony and Marjanovic, Zora and Marosi, Christine and Martin, Ellis and Meillon, Luis and Messas, Emmanuel and Moreira, Antonio and Demir, Ahmet M and Ndour, Arlette and Nguessan, Michel and Otero-Candelera, Remedios and Pachon Olmos, Vanessa and Pais, Ana and Posch, Florian and Preusser, Matthias and Riess, Hanno and Righini, Marc and Rothschild, Cynthia and Roussin, Andre and Rueda-Camino, José Antonio and Ruiz-Artacho, Pedro and Saseedharan, Sanjith and Shamseddine, Ali and Soff, Gerald and Stricker, Hans and Tagalakis, Vicky and Taher, Ali and Toussaint, Toutou and Trujillo-Santos, Javier and Villiers, Stéphane and Wong, Raymond and Yamada, Norizaku and International Initiative on Thrombosis and Cancer (ITAC) advisory panel and Int Initiative Thrombosis Canc ITA
The lancet oncology, ISSN 1470-2045, 2019, Volume 20, Issue 10, pp. e566 - e581
SummaryVenous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at a high risk of VTE recurrence and... 
Hematology, Oncology, and Palliative Medicine | AMBULATORY PATIENTS | LUNG-CANCER | ONCOLOGY | PHARMACOLOGICAL THROMBOPROPHYLAXIS | DALTEPARIN THROMBOPROPHYLAXIS | THERAPEUTIC ANTICOAGULATION | RECEIVING CHEMOTHERAPY | MOLECULAR-WEIGHT HEPARIN | DIRECT ORAL ANTICOAGULANTS | VENA-CAVA FILTERS | INTRACRANIAL HEMORRHAGE
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 11/2019, Volume 119, Issue 11, pp. 1713 - 1715
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 6, pp. 1240 - 1248
Summary Hospital-associated venous thromboembolism (VTE) is a leading cause of premature death and disability worldwide. Evidence-based guidelines recommend... 
Trial Protocol Design Paper | Pulmonary embolism | Anticoagulants | Rivaroxaban | Deep-vein thrombosis | Medical patients | Thromboprophylaxis | Venous thromboembolism
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 03/2011, Volume 105, Issue 3, pp. 444 - 453
Four phase III studies compared oral rivaroxaban with subcutaneous enoxaparin for the prevention of venous thromboembolism (VTE) after total hip or knee... 
pooled analysis | venous thromboembolism | rivaroxaban | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | ENOXAPARIN | SURGERY | Pooled analysis | THROMBOSIS | RANDOMIZED-TRIAL | HEPARIN | REPLACEMENT | DABIGATRAN ETEXILATE | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY | DURATION
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2018, Volume 118, Issue 1, pp. 082 - 089
Abstract Background  Improved thromboprophylaxis for acutely ill medical patients relies on valid predictions of thrombotic risks. Our aim was to compare the... 
Coagulation and Fibrinolysis | clinical studies | risk factors | prophylaxis | venous thrombosis | VTE | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY
Journal Article